NHS Blood & Transplant
NHS Blood & Transplant's (NHSBT) Cellular and Molecular Therapies (CMT) function provides GMP manufacturing and translational support for academic and commercial advanced therapy programmes. Benefiting from integrated NHS infrastructure, we deliver plasmid, viral vector, and cell therapy manufacturing—accelerating the transition from research innovation to clinical application through a collaborative, flexible, cost recovery model to maximise patient access to life-changing therapies